Cite
HARVARD Citation
Ansari, A. et al. (2018). Editorial: an argument for low‐dose thiopurine allopurinol combination use as first‐line therapy in inflammatory bowel disease. Alimentary pharmacology & therapeutics. 48 (1), pp. 97-98. [Online].